Dr. Sandra D'Angelo, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Soft Tissue Sarcoma
Studies Cancer
10 reported clinical trials
18 drugs studied
Area of expertise
1Soft Tissue Sarcoma
Stage IV
Stage III
metastatic
2Cancer
Stage IV
Stage III
metastatic
Affiliated Hospitals
Clinical Trials Sandra D'Angelo, MD is currently running
Retifanlimab + Chemotherapy
for Soft Tissue Sarcoma
This study is being done to find out whether the study drug Retifanlimab, a monoclonal antibody against the PD-1 protein, combined with gemcitabine and docetaxel, is a safe and effective treatment for your disease. Gemcitabine and docetaxel are chemotherapy drugs that are commonly used to treat soft tissue sarcoma. Retifanlimab is an experimental drug that boosts the immune system's ability to fight cancer cells. The study researchers think that Retifanlimab may help gemcitabine and docetaxel work better against soft tissue sarcoma that is either locally advanced or has spread beyond its original location (metastasized), and it cannot be removed with surgery (unresectable).
Recruiting1 award Phase 1 & 213 criteria
Adoptive Cell Therapy
for Cancer
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Recruiting1 award Phase 1
More about Sandra D'Angelo, MD
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sandra D'Angelo, MD has experience with
- Nivolumab
- NKTR-214
- Avelumab
- DCC-3014
- INCMGA00012
- Palbociclib
Breakdown of trials Sandra D'Angelo, MD has run
Soft Tissue Sarcoma
Cancer
Liposarcoma
Sarcoma
Uterine Leiomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandra D'Angelo, MD specialize in?
Sandra D'Angelo, MD focuses on Soft Tissue Sarcoma and Cancer. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Sandra D'Angelo, MD currently recruiting for clinical trials?
Yes, Sandra D'Angelo, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Sandra D'Angelo, MD has studied deeply?
Yes, Sandra D'Angelo, MD has studied treatments such as Nivolumab, NKTR-214, Avelumab.
What is the best way to schedule an appointment with Sandra D'Angelo, MD?
Apply for one of the trials that Sandra D'Angelo, MD is conducting.
What is the office address of Sandra D'Angelo, MD?
The office of Sandra D'Angelo, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.